Analysis of minicircle classes in Leishmania (Viannia) species.

S. Brewster,Douglas C. Barker

DOI: https://doi.org/10.1016/S0035-9203(02)90052-0

2002-04-01

Transactions of the Royal Society of Tropical Medicine and Hygiene

Abstract:

What problem does this paper attempt to address?

Role of the CASZ1 transcription factor in tissue development and disease

Tiantian Liu,Tao Li,Shaorui Ke

DOI: https://doi.org/10.1186/s40001-023-01548-y

2023-12-05

Abstract:The zinc finger transcription factor gene, CASZ1/Castor (Castor zinc finger 1), initially identified in Drosophila, plays a critical role in neural, cardiac, and cardiovascular development, exerting a complex, multifaceted influence on cell fate and tissue morphogenesis. During neurogenesis, CASZ1 exhibits dynamic expression from early embryonic development to the perinatal period, constituting a key regulator in this process. Additionally, CASZ1 controls the transition between neurogenesis and gliomagenesis. During human cardiovascular system development, CASZ1 is essential for cardiomyocyte differentiation, cardiac morphogenesis, and vascular morphology homeostasis and formation. The deletion or inactivation of CASZ1 mutations can lead to human developmental diseases or tumors, including congenital heart disease, cardiovascular disease, and neuroblastoma. CASZ1 can be used as a biomarker for disease prevention and diagnosis as well as a prognostic indicator for cancer. This review explores the unique functions of CASZ1 in tissue morphogenesis and associated diseases, offering new insights for elucidating the molecular mechanisms underlying diseases and identifying potential therapeutic targets for disease prevention and treatment.
CASZ1 Loss-of-function Mutation Associated with Congenital Heart Disease.

Ri-Tai Huang,Song Xue,Juan Wang,Jian-Yun Gu,Jia-Hong Xu,Yan-Jie Li,Ning Li,Xiao-Xiao Yang,Hua Liu,Xiao-Dong Zhang,Xin-Kai Qu,Ying-Jia Xu,Xing-Biao Qiu,Ruo-Gu Li,Yi-Qing Yang

DOI: https://doi.org/10.1016/j.gene.2016.09.044

IF: 3.913

2016-01-01

Gene

Abstract:As the most common form of birth defect in humans, congenital heart disease (CHD) is associated with substantial morbidity and mortality in both children and adults. Increasing evidence demonstrates that genetic defects play a pivotal role in the pathogenesis of CHD. However, CHD is of great heterogeneity, and in an overwhelming majority of cases, the genetic determinants underpinning CHD remain elusive. In the present investigation, the coding exons and flanking introns of the CASZ1 gene, which codes for a zinc finger transcription factor essential for the cardiovascular morphogenesis, were sequenced in 172 unrelated patients with CHD. As a result, a novel heterozygous CASZ1 mutation, p.L38P, was identified in an index patient with congenital ventricular septal defect (VSD). Genetic scanning of the mutation carrier's available family members revealed that the mutation was present in all affected patients but absent in unaffected individuals. Analysis of the proband's pedigree showed that the mutation co-segregated with VSD, which was transmitted as an autosomal dominant trait with complete penetrance. The missense mutation, which altered the amino acid that was highly conserved evolutionarily, was absent in 200 unrelated, ethnically-matched healthy subjects used as controls. Functional deciphers by using a dual-luciferase reporter assay system unveiled that the mutant CASZ1 had significantly reduced transcriptional activity as compared with its wild-type counterpart. To the best of our knowledge, the current study firstly identifies CASZ1 as a new gene predisposing to CHD in humans, which provides novel insight into the molecular mechanisms underlying CHD and a potential therapeutic target for CASZ1-associated CHD, suggesting potential implications for personalized prophylaxis and therapy of CHD.
CASZ1 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

Xing-Biao Qiu,Xin-Kai Qu,Ruo-Gu Li,Hua Liu,Ying-Jia Xu,Min Zhang,Hong-Yu Shi,Xu-Min Hou,Xu Liu,Fang Yuan,Yu-Min Sun,Jun Wang,Ri-Tai Huang,Song Xue,Yi-Qing Yang

DOI: https://doi.org/10.1515/cclm-2016-0612

2017-01-01

Clinical Chemistry and Laboratory Medicine (CCLM)

Abstract:Background: The zinc finger transcription factor CASZ1 plays a key role in cardiac development and postnatal adaptation, and in mice, deletion of the CASZ1 gene leads to dilated cardiomyopathy (DCM). However, in humans whether genetically defective CASZ1 contributes to DCM remains unclear.Methods: The coding exons and splicing junction sites of the CASZ1 gene were sequenced in 138 unrelated patients with idiopathic DCM. The available family members of the index patient harboring an identified CASZ1 mutation and 200 unrelated, ethnically matched healthy individuals used as controls were genotyped for CASZ1. The functional characteristics of the mutant CASZ1 were analyzed in contrast to its wild-type counterpart using a luciferase reporter assay system.Results: A novel heterozygous CASZ1 mutation, p. K351X, was identified in an index patient with DCM. Genetic analysis of the mutation carrier's family showed that the mutation co-segregated with DCM, which was transmitted in an autosomal dominant pattern with complete penetrance. The nonsense mutation, which was absent in 400 referential chromosomes, altered the amino acid that was highly conserved evolutionarily. Biological investigations revealed that the mutant CASZ1 had no transcriptional activity.Conclusions: The current study reveals CASZ1 as a new gene responsible for human DCM, which provides novel mechanistic insight and potential therapeutic target for CASZ1-associated DCM, implying potential implications in improved prophylactic and therapeutic strategies for DCM, the most common type of primary myocardial disease.
Critical Role of Znhit1 for Postnatal Heart Function and Vacuolar Cardiomyopathy

Yingchao Shi,Wenli Fan,Mingjie Xu,Xinhua Lin,Wukui Zhao,Zhongzhou Yang

DOI: https://doi.org/10.1172/jci.insight.148752

IF: 9.4958

2022-01-01

JCI Insight

Abstract:Ca2+ is critical for cardiac electrical conduction and contractility, and aberrant Ca2+ homeostasis causes arrhythmia and heart failure. Chromatin remodeling modulates gene expression involved in cardiac sarcomere assembly and postnatal heart function. However, the chromatin-remodeling regulatory mechanism of cardiac Ca2+ homeostasis is unknown. Here, we found that Znhit1, a core subunit of the SRCAP remodeling complex, was essential for heart function. Deletion of Znhit1 in postnatal hearts of mice resulted in arrhythmia, idiopathic vacuolar cardiomyopathy, rapid heart failure, and premature sudden death. In addition, the level of Casq1, a sarcoplasmic reticulum Ca2+ regulatory protein, was massively elevated while SERCA2a showed reduced protein level. Mechanistically, the Znhit1 modulated the expression of Casq1 and SERCA2a by depositing H2A.Z at their promoters. Deletion of Casq1 could substantially alleviate the vacuolar formation in Znhit1 Casq1 KO mice. These findings demonstrate that Znhit1 is required for postnatal heart function and maintains cardiac Ca2+ homeostasis and that accumulation of Casq1 might be a causative factor for vacuolar cardiomyopathy.
Loss of GLTSCR1 Causes Congenital Heart Defects by Regulating NPPA Transcription

Fengyan Han,Beibei Yang,Yan Chen,Lu Liu,Xiaoqing Cheng,Jiaqi Huang,Ke Zhou,Dandan Zhang,Enping Xu,Maode Lai,Bingjian Lv,Hongqiang Cheng,Honghe Zhang

DOI: https://doi.org/10.1007/s10456-023-09869-6

IF: 10.658

2023-01-01

Angiogenesis

Abstract:Precise and specific spatiotemporal domains of gene expression regulation are critical for embryonic development. Recent studies have identified GLTSCR1 as a gene transcriptional elongation regulator in cancer research. However, the function of GLTSCR1, especially in embryonic development, remains poorly understood. Here, we found that GLTSCR1 was essential for cardiac development because Gltscr1 knockout (Gltscr1-/-) led to embryonic lethality in mice with severe congenital heart defects (CHDs). Ventricular septal defect and double outflow right ventricular were also observed in neural crest cells with conditional deletion of Gltscr1, which were associated with neonatal lethality in mice. Mechanistically, GLTSCR1 deletion promoted NPPA expression by coordinating the CHD risk G allele of rs56153133 in the NPPA enhancer and releasing the transcription factor ZNF740-binding site on the NPPA promoter. These findings demonstrated that GLTSCR1 acts as a candidate CHD-related gene.
Essential Role of MESP1-RING1A Complex in Cardiac Differentiation

Qianqian Liang,Siqing Wang,Xinyan Zhou,Yongbo Li,Shenghui Xing,Yi'ou Sha,Fuling Yang,Wenjun Huang,Nanbo Liu,Zhetao Li,Yufei Chen,Yichi Xu,Ping Zhu,Fei Lan,Ning Sun

DOI: https://doi.org/10.1016/j.devcel.2022.10.009

IF: 13.417

2022-01-01

Developmental Cell

Abstract:Heart development is controlled by a complex transcriptional network composed of transcription factors and epigenetic regulators. Mutations in key developmental transcription factor MESP1 and chromatin factors, such as PRC1 and cohesin components, have been found in human congenital heart diseases (CHDs), although their functional mechanism during heart development remains elusive. Here, we find that MESP1 interacts with RING1A/RING1, the core component of PRC1. RING1A depletion impairs human cardiomyocyte differentiation, and cardiac abnormalities similar to those in patients with MESP1 mutations were observed in Ring1A knockout mice. Mechanistically, MESP1 associates with RING1A to activate cardiogenic genes through promoter-enhancer interactions regulated by cohesin and CTCF and histone acetylation mediated by p300. Importantly, CHD mutations of MESP1 significantly affect such mechanisms and impair target gene activation. Together, our results demonstrate the importance of MESP1-RING1A complex in heart development and provide insights into the pathogenic mechanisms of CHDs caused by mutations in MESP1, PRC1, and cohesin components.
Loss of Sec-1 Family Domain-Containing 1 (scfd1) Causes Severe Cardiac Defects and Endoplasmic Reticulum Stress in Zebrafish

Inken G Huttner,Celine F Santiago,Arie Jacoby,Delfine Cheng,Gunjan Trivedi,Stephen Cull,Jasmina Cvetkovska,Renee Chand,Joachim Berger,Peter D Currie,Kelly A Smith,Diane Fatkin

DOI: https://doi.org/10.3390/jcdd10100408

2023-09-22

Abstract:Dilated cardiomyopathy (DCM) is a common heart muscle disorder that frequently leads to heart failure, arrhythmias, and death. While DCM is often heritable, disease-causing mutations are identified in only ~30% of cases. In a forward genetic mutagenesis screen, we identified a novel zebrafish mutant, heart and head (hahvcc43), characterized by early-onset cardiomyopathy and craniofacial defects. Linkage analysis and next-generation sequencing identified a nonsense variant in the highly conserved scfd1 gene, also known as sly1, that encodes sec1 family domain-containing 1. Sec1/Munc18 proteins, such as Scfd1, are involved in membrane fusion regulating endoplasmic reticulum (ER)/Golgi transport. CRISPR/Cas9-engineered scfd1vcc44 null mutants showed severe cardiac and craniofacial defects and embryonic lethality that recapitulated the phenotype of hahvcc43 mutants. Electron micrographs of scfd1-depleted cardiomyocytes showed reduced myofibril width and sarcomere density, as well as reticular network disorganization and fragmentation of Golgi stacks. Furthermore, quantitative PCR analysis showed upregulation of ER stress response and apoptosis markers. Both heterozygous hahvcc43 mutants and scfd1vcc44 mutants survived to adulthood, showing chamber dilation and reduced ventricular contraction. Collectively, our data implicate scfd1 loss-of-function as the genetic defect at the hahvcc43 locus and provide new insights into the role of scfd1 in cardiac development and function.
The Axenfeld-Rieger Syndrome Gene FOXC1 Contributes to Left-Right Patterning

Paul W. Chrystal,Curtis R. French,Francesca Jean,Serhiy Havrylov,Suey van Baarle,Ann-Marie Peturson,Pengfei Xu,J. Gage Crump,David B. Pilgrim,Ordan J. Lehmann,Andrew J. Waskiewicz

DOI: https://doi.org/10.1101/2020.05.28.120915

2020-01-01

bioRxiv

Abstract:Normal body situs requires precise spatiotemporal expression of the Nodal-Lefty-Pitx2 cascade in the lateral plate mesoderm. The ultimate output of this patterning is establishment of the left-right axis, which provides vital cues for correct organ formation and function. Mutations, deletions and duplications in PITX2 and FOXC1 lead to the rare genetic disease Axenfeld-Rieger syndrome (ARS). While situs defects are not a recognised feature of ARS, partial penetrance of cardiac septal defects and valve incompetence is observed; both of these congenital heart defects (CHDs) also occur following disruption of left-right patterning. Here we investigated whether foxc1 genes have a critical role in specifying organ situs. We demonstrate that CRISPR/Cas9 generated mutants for the zebrafish paralogs foxc1a and foxc1b recapitulate ARS phenotypes including craniofacial dysmorphism, hydrocephalus and intracranial haemorrhage. Furthermore, foxc1a-/-; foxc1b-/- mutant animals display cardiac and gut situs defects. Modelling FOXC1 duplication by transient mRNA overexpression revealed that increased foxc1 dosage also results in organ situs defects. Analysis of known left-right patterning genes revealed a loss in expression of the NODAL antagonist lefty2 in the lateral plate mesoderm. Consistently, LEFTY2 mutations are known to cause human cardiac situs defects. Our data reveal a novel role for the forkhead-box transcription factor foxc1 in patterning of the left-right axis, and provide a plausible mechanism for the incidence of congenital heart defects in Axenfeld-Rieger syndrome patients. Author Summary This manuscript investigates the functional consequences of abrogating the activity of Foxc1 (Forkhead Box C1). We demonstrate that loss of zebrafish foxc1a and foxc1b results in phenotypes that resemble human patients with deletions in the FOXC1 locus. Notably, such phenotypes include alterations to the morphology of the heart. Investigations into the mechanisms underlying this phenotype led to the discovery that Foxc1 functions as a regulator of left-right patterning. Most components of left-right specification function normally in foxc1a/b mutants, but there is a pronounced loss of lefty2, a known inhibitor of Nodal signaling. This supports a model in which Foxc1 regulates situs of the heart via the regulation of Lefty2.
The Axenfeld–Rieger Syndrome Gene FOXC1 Contributes to Left–Right Patterning

Paul W. Chrystal,Curtis R. French,Francesca Jean,Serhiy Havrylov,Suey van Baarle,Ann-Marie Peturson,Pengfei Xu,J. Gage Crump,David B. Pilgrim,Ordan J. Lehmann,Andrew J. Waskiewicz

DOI: https://doi.org/10.3390/genes12020170

IF: 4.141

2021-01-01

Genes

Abstract:Precise spatiotemporal expression of the Nodal-Lefty-Pitx2 cascade in the lateral plate mesoderm establishes the left–right axis, which provides vital cues for correct organ formation and function. Mutations of one cascade constituent PITX2 and, separately, the Forkhead transcription factor FOXC1 independently cause a multi-system disorder known as Axenfeld–Rieger syndrome (ARS). Since cardiac involvement is an established ARS phenotype and because disrupted left–right patterning can cause congenital heart defects, we investigated in zebrafish whether foxc1 contributes to organ laterality or situs. We demonstrate that CRISPR/Cas9-generated foxc1a and foxc1b mutants exhibit abnormal cardiac looping and that the prevalence of cardiac situs defects is increased in foxc1a−/−; foxc1b−/− homozygotes. Similarly, double homozygotes exhibit isomerism of the liver and pancreas, which are key features of abnormal gut situs. Placement of the asymmetric visceral organs relative to the midline was also perturbed by mRNA overexpression of foxc1a and foxc1b. In addition, an analysis of the left–right patterning components, identified in the lateral plate mesoderm of foxc1 mutants, reduced or abolished the expression of the NODAL antagonist lefty2. Together, these data reveal a novel contribution from foxc1 to left–right patterning, demonstrating that this role is sensitive to foxc1 gene dosage, and provide a plausible mechanism for the incidence of congenital heart defects in Axenfeld–Rieger syndrome patients.
Functional screening of congenital heart disease risk loci identifies 5 genes essential for heart development in zebrafish

Jianlong Ma,Yayun Gu,Juanjuan Liu,Jingmei Song,Tao Zhou,Min Jiang,Yang Wen,Xuejiang Guo,Zuomin Zhou,Jiahao Sha,Jianbo He,Zhibin Hu,Lingfei Luo,Mingxi Liu

DOI: https://doi.org/10.1007/s00018-022-04669-5

IF: 8

2022-01-01

Cellular and Molecular Life Sciences

Abstract:Congenital heart disease (CHD) is the most common birth defect worldwide and a main cause of perinatal and infant mortality. Our previous genome-wide association study identified 53 SNPs that associated with CHD in the Han Chinese population. Here, we performed functional screening of 27 orthologous genes in zebrafish using injection of antisense morpholino oligos. From this screen, 5 genes were identified as essential for heart development, including iqgap2 , ptprt , ptpn22 , tbck and maml3 . Presumptive roles of the novel CHD-related genes include heart chamber formation ( iqgap2 and ptprt ) and atrioventricular canal formation ( ptpn22 and tbck ). While deficiency of maml3 led to defective cardiac trabeculation and consequent heart failure in zebrafish embryos. Furthermore, we found that maml3 mutants showed decreased cardiomyocyte proliferation which caused a reduction in cardiac trabeculae due to inhibition of Notch signaling. Together, our study identifies 5 novel CHD-related genes that are essential for heart development in zebrafish and first demonstrates that maml3 is required for Notch signaling in vivo.
Endothelial Loss of ETS1 Impairs Coronary Vascular Development and Leads to Ventricular Non-Compaction

Lu Wang,Lizhu Lin,Hui Qi,Ju Chen,Paul Grossfeld

DOI: https://doi.org/10.1161/CIRCRESAHA.121.319955

2022-08-19

Abstract:Rationale: Jacobsen syndrome is a rare chromosomal disorder caused by deletions in the long arm of human chromosome 11, resulting in multiple developmental defects including congenital heart defects. Combined studies in humans and genetically engineered mice implicate that loss of ETS1 (E26 transformation specific 1) is the cause of congenital heart defects in Jacobsen syndrome, but the underlying molecular and cellular mechanisms are unknown. Objective: To determine the role of ETS1 in heart development, specifically its roles in coronary endothelium and endocardium and the mechanisms by which loss of ETS1 causes coronary vascular defects and ventricular noncompaction. Methods and results: ETS1 global and endothelial-specific knockout mice were used. Phenotypic assessments, RNA sequencing, and chromatin immunoprecipitation analysis were performed together with expression analysis, immunofluorescence and RNAscope in situ hybridization to uncover phenotypic and transcriptomic changes in response to loss of ETS1. Loss of ETS1 in endothelial cells causes ventricular noncompaction, reproducing the phenotype arising from global deletion of ETS1. Endothelial-specific deletion of ETS1 decreased the levels of Alk1 (activin receptor-like kinase 1), Cldn5 (claudin 5), Sox18 (SRY-box transcription factor 18), Robo4 (roundabout guidance receptor 4), Esm1 (endothelial cell specific molecule 1) and Kdr (kinase insert domain receptor), 6 important angiogenesis-relevant genes in endothelial cells, causing a coronary vasculature developmental defect in association with decreased compact zone cardiomyocyte proliferation. Downregulation of ALK1 expression in endocardium due to the loss of ETS1, along with the upregulation of TGF (transforming growth factor)-β1 and TGF-β3, occurred with increased TGFBR2/TGFBR1/SMAD2 signaling and increased extracellular matrix expression in the trabecular layer, in association with increased trabecular cardiomyocyte proliferation. Conclusions: These results demonstrate the importance of endothelial and endocardial ETS1 in cardiac development. Delineation of the gene regulatory network involving ETS1 in heart development will enhance our understanding of the molecular mechanisms underlying ventricular and coronary vascular developmental defects and will lead to improved approaches for the treatment of patients with congenital heart disease.
Overexpression of Jazf1 induces cardiac malformation through the upregulation of pro-apoptotic genes in mice

Ki Beom Bae,Myoung Ok Kim,Dong Hoon Yu,Mi Jung Shin,Hei Jung Kim,Hyung Soo Yuh,Young Rae Ji,Jae-Young Kim,Jin Man Kim,Byung Hwa Hyun,Hwi Cheul Lee,Won Kyong Chang,Soo Bong Park,Do Hyung Kim,Hyun-Shik Lee,Yeon-Sik Choo,Sanggyu Lee,Zae Young Ryoo

DOI: https://doi.org/10.1007/s11248-010-9476-4

2011-01-09

Transgenic Research

Abstract:The transcription factor Juxtaposed with another zinc finger gene 1 (JAZF1) is a zinc finger protein that binds to the nuclear orphan receptor TR4. Recent evidence indicates that TR4 receptor functions as both a positive and negative regulator of transcription, but the role of JAZF1 in transcriptional mechanisms has not been elucidated. Recently, the incidence rate of congenital heart malformations was reported to be significantly elevated in patients who had neurofibromatosis 1 (NF1) with chromosomal microdeletion syndrome. Furthermore, Joined to JAZF1 (SUZ12) is expressed at high levels in the hearts of adult patients with NF1 microdeletion syndrome. Therefore, we hypothesized that ectopic expression of JAZF1 may lead to cardiac malformations that deleteriously affect the survival of neonates and adults. We sought to elucidate the role of JAZF1 in cardiac development using a Jazf1-overexpressing (Jazf1-Tg) mouse model. In Jazf1-Tg mice, Jazf1 mRNA expression was significantly elevated in the heart. Jazf1-Tg mice also showed cardiac defects, such as high blood pressure, electrocardiogram abnormalities, apoptosis of cardiomyocytes, ventricular non-compaction, and mitochondrial defects. In addition, we found that the expression levels of pro-apoptotic genes were elevated in the hearts of Jazf1-Tg mice. These findings suggest that Jazf1 overexpression may induce heart failure symptoms through the upregulation of pro-apoptotic genes in cardiomyocytes.

biochemistry & molecular biology,biochemical research methods,biotechnology & applied microbiology
SMC3 Contributes to Heart Development by Regulating Super-Enhancer Associated Genes.

Bowen Zhang,Yongchang Zhu,Zhen Zhang,Feizhen Wu,Xiaojing Ma,Wei Sheng,Ranran Dai,Zhenglong Guo,Weili Yan,Lili Hao,Guoying Huang,Duan Ma,Bingtao Hao,Jing Ma

DOI: https://doi.org/10.1038/s12276-024-01293-0

2024-01-01

Abstract:Abnormal cardiac development has been observed in individuals with Cornelia de Lange syndrome (CdLS) due to mutations in genes encoding members of the cohesin complex. However, the precise role of cohesin in heart development remains elusive. In this study, we aimed to elucidate the indispensable role of SMC3, a component of the cohesin complex, in cardiac development and its underlying mechanism. Our investigation revealed that CdLS patients with SMC3 mutations have high rates of congenital heart disease (CHD). We utilized heart-specific Smc3-knockout (SMC3-cKO) mice, which exhibit varying degrees of outflow tract (OFT) abnormalities, to further explore this relationship. Additionally, we identified 16 rare SMC3 variants with potential pathogenicity in individuals with isolated CHD. By employing single-nucleus RNA sequencing and chromosome conformation capture high-throughput genome-wide translocation sequencing, we revealed that Smc3 deletion downregulates the expression of key genes, including Ets2, in OFT cardiac muscle cells by specifically decreasing interactions between super-enhancers (SEs) and promoters. Notably, Ets2-SE-null mice also exhibit delayed OFT development in the heart. Our research revealed a novel role for SMC3 in heart development via the regulation of SE-associated genes, suggesting its potential relevance as a CHD-related gene and providing crucial insights into the molecular basis of cardiac development. Understanding heart development is vital as defects in this process are a major cause of birth abnormalities. This study focuses on a protein, SMC3, and its role in heart development. Experiments were conducted on mice genetically altered to lack SMC3 in heart cells. Researchers found that mice without SMC3 had various heart defects, like those seen in humans with congenital heart disease. They also found mutations in the SMC3 gene in patients with congenital heart disease, suggesting a link between SMC3 and heart development in humans. The findings reveal that SMC3 plays a crucial role in heart development, with its absence leading to significant heart defects in mice. These results suggest a potential genetic cause for some forms of congenital heart disease in humans.This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author.Introduction
Alteration in Connexin 43 Gap Junction Gene Dosage Impairs Conotruncal Heart Development

Guoying Huang,Andy Wessels,Brian N. Smith,Kérsti K. Linask,Janet L. Ewart,Cecilia W. Lo

DOI: https://doi.org/10.1006/dbio.1998.8891

IF: 3.148

1998-01-01

Developmental Biology

Abstract:Connexin 43 (Cx43) knockout mice and transgenic mice (CMV43) overexpressing the Cx43 gap junction gene exhibit heart defects involving the conotruncus and right ventricle. Based on the heart phenotype and Cx43 gene and transgene expression pattern, we previously proposed that the heart defects may reflect a role for gap junctions in the modulation of cardiac neural crest development. To further elucidate the mechanism by which these heart defects may arise, fetal heart structure and function in these transgenic and knockout mice were examined by magnetic resonance microscopy and Doppler echocardiography. Magnetic resonance microscopy of E14.5 fetuses revealed an enlargement of the right ventricular chamber in the heterozygous Cx43 knockout and CMV43 transgenic mice. This was accompanied by thinning of the chamber wall. In the homozygous Cx43 knockout mouse, heart malformation was also restricted to the right ventricle. This was generally characterized by two pouches at the base of the pulmonary outflow tract, but occasionally hearts with a single pouch were found. Magnetic resonance microscopy showed in some of the CMV43 and Cx43 knockout mice an attenuation of the ductus arteriosus, a phenotype which may be indicative of outflow tract obstruction. This was confirmed by thein uteroDoppler echocardiography, which showed increased outflow velocity in E12.5 to 14.5 CMV43 and Cx43 knockout fetuses. In some of these fetuses, Doppler analysis also revealed arrhythmia and absence of isovolemic contraction time. Further examination of these hearts by histology and immunohistochemistry showed abnormal myocardial development in the conotruncus. Particularly interesting was the presence of abundant subendocardial fibrous tissue expressing smooth muscle actin. In the developing heart, such mesenchyme in the outflow tract is usually considered neural crest-derived tissue. Together, these results confirm the importance of Cx43 gene dosage in conotruncal heart development and suggest that this likely involves a role for Cx43 gap junctions in cardiac crest development. In future studies, these transgenic mice may serve as valuable animal models for further studying the role of gap junctions and cardiac crest cells in conotruncal heart development.
Chromatin Remodelling Complex Dosage Modulates Transcription Factor Function in Heart Development

Jun K. Takeuchi,Xin Lou,Jeffrey M. Alexander,Hiroe Sugizaki,Paul Delgado-Olguín,Alisha K. Holloway,Alessandro D. Mori,John N. Wylie,Chantilly Munson,Yonghong Zhu,Yu-Qing Zhou,Ru-Fang Yeh,R. Mark Henkelman,Richard P. Harvey,Daniel Metzger,Pierre Chambon,Didier Y. R. Stainier,Katherine S. Pollard,Ian C. Scott,Benoit G. Bruneau

DOI: https://doi.org/10.1038/ncomms1187

IF: 16.6

2011-01-01

Nature Communications

Abstract:Dominant mutations in cardiac transcription factor genes cause human inherited congenital heart defects (CHDs); however, their molecular basis is not understood. Interactions between transcription factors and the Brg1/Brm-associated factor (BAF) chromatin remodelling complex suggest potential mechanisms; however, the role of BAF complexes in cardiogenesis is not known. In this study, we show that dosage of Brg1 is critical for mouse and zebrafish cardiogenesis. Disrupting the balance between Brg1 and disease-causing cardiac transcription factors, including Tbx5, Tbx20 and Nkx2-5, causes severe cardiac anomalies, revealing an essential allelic balance between Brg1 and these cardiac transcription factor genes. This suggests that the relative levels of transcription factors and BAF complexes are important for heart development, which is supported by reduced occupancy of Brg1 at cardiac gene promoters in Tbx5 haploinsufficient hearts. Our results reveal complex dosage-sensitive interdependence between transcription factors and BAF complexes, providing a potential mechanism underlying transcription factor haploinsufficiency, with implications for multigenic inheritance of CHDs.
Cardiotoxicity Related to Long‐Term Trastuzumab Therapy in Metastatic Breast Cancer: The Potential Role of Treatment Duration and Cardiac Risk Factors

B. Pistilli,A. Marcellusi,L. Latini,R. Accardi,B. Ferretti,G. Benedetti

DOI: https://doi.org/10.1111/tbj.12412

2015-05-01

The Breast Journal

Abstract:To the Editor: Since its approval, trastuzumab (Herceptin, F. Hoffmann-La Roche Ltd., Basel Switzerland) has dramatically improved outcomes of patients with Human Epidermal growth factor Receptor 2 (HER2+) metastatic breast cancer (MBC) and has ushered in a new era in clinical practice, providing innovative insights on long-term treatment (1–3). Indeed, several studies have shown that long-term HER2 suppression should be maintained in HER2+ MBC both beyond disease response(4,5) and progression (6,7). Therefore, a growing number of patients have been receiving longterm trastuzumab administration, as maintenance monotherapy or in combination with multiple lines of chemotherapy. However, over the last 10 years, trastuzumab cardiotoxicity, ranging from asymptomatic left ventricular dysfunction to congestive heart failure (1,8,9), has emerged as a critical concern. Differently than anthracycline, trastuzumab cardiotoxicity is neither dose-related nor cumulative and appears generally reversible (6). Its pathogenesis seems partly due to antibody-directed cellular cytotoxicity, to HER2 downregulation in cardiomyocites and, as recently demonstrated, to destabilization of mitochondrial membrane with Adenosin Triphosphate depletion and subsequent cardiomyocite contractile dysfunction (4). The large trastuzumab adjuvant trials, including the recent analysis of 2-year arm of HERA trial, showed a low incidence of Cardiac Events (CEs) during adjuvant trastuzumab and demonstrated that the cumulative incidence of CEs tends to plateau after treatment completion, thus suggesting that cardiotoxicity occurs early and mainly while on treatment (5,9). However, these data refer to patients strictly selected on the basis of cardiac risk factors and exposed to trastuzumab for a well-defined time. Conversely, in metastatic setting the cardiac safety of prolonged trastuzumab administration have yet to be clarified, despite an increasing number of patients having received trastuzumab for several years. Data on incidence, onset, and outcome of cardiotoxicity in MBC patients receiving long-term trastuzumb therapy are lacking. Notably, very few studies have weighed benefits and cardiac harms of prolonged trastuzumab therapies in a “real world” MBC population, in which comorbidities, previous treatments and general aging could represent heavy cardiac risk factors (7,10–12). To determine whether duration of trastuzumab and the presence of cardiac risk factors can affect the cardiac safety of trastuzumab in metastatic setting, we conducted a retrospective analysis of 62 HER2+ MBC patients treated with trastuzumab and at least one concomitant chemotherapy regimen at our Institution from December 2003 to June 2012. The median age was 52 years (range 29–76 years); the median cumulative time receiving trastuzumab resulted 29.5 months (range 3–99 months). Forty patients (64.5%) received trastuzumab without interruption from the diagnosis of MBC, for a median time of 29 months (range 3–99 months); in the remaining patients 1 or 2 interruptions were recorded with a median interruption time of 7 months (range 2–30 months). According to previous published data (9,10), we evaluated, in univariate and multivariate Cox regression analysis, the following variables as potential cardiac risk factors: age at start of trastuzumab, body mass index (BMI, <25 versus ≥25 kg/m), antihypertensive therapy, history of cardiac disease, diabetes, smoking, radiotherapy on the left chest wall, prior exposure to anthracyclines, baseline Left Ventricular Ejection Fraction (LVEF), continued/interrupted trastuzumab exposure and duration of concomitant exposure to chemotherapy and trastuzumab. In univariate analysis Address correspondence and reprint requests to: Barbara Pistilli, Oncology Unit, ASUR Marche 3, Macerata Hospital, Via S. Lucia, 1, Macerata 62100, Italy, or e-mail: barbara.pistilli@sanita.marche.it
Abstract P2059: Poly(rC)-binding Protein-1 (Pcbp1) Is Essential For Heart Development

Yao Wei Lu,Zhuomin Liang,Haipeng Guo,Tiago Fernandes,Xiaoyun Hu,Ramon Espinoza-Lewis,Douglas B Cowan,Hong Chen,Da-Zhi Wang

DOI: https://doi.org/10.1161/res.131.suppl_1.p2059

IF: 23.213

2022-08-05

Circulation Research

Abstract:Rationale: Proper development of the heart relies on a tightly regulated, yet diverse, pattern of gene expression that is governed by transcriptional, post-transcriptional, and translational processes. Congenital heart disease (CHD) is the most common birth defect and a leading cause of morbidity and mortality in children. While the genetic cause of some types of CHD has been identified, the molecular basis for the rest remains elusive. Poly(rC)-binding protein 1 (Pcbp1) is a RNA-binding protein that regulates RNA processing as well as post-transcriptional and translational processes in a variety of biological systems. Hypothesis: Pcbp1 play a critical role in regulating heart development by governing Notch and UPR pathways and mediating proper Aars2 gene splicing. Methods and Results: Germline deletion of Pcbp1 results in lethality before embryonic day (E) 8.5. We generated a cardiac-specific deletion of Pcbp1 by crossing Pcbp1-Flox with cTNT-Cre mice (Pcbp1-cKO cTNT ) and found that Pcbp1-cKO cTNT mice is 50% lethal perinatally. Embryonic hearts of Pcbp1-cKO cTNT mice displayed ventricular non-compaction and abnormal ventricular apex formation. Deep RNA sequencing of Pcbp1-cKO cTNT hearts revealed alteration of gene expression profiles reflective on ventricular maturation delay and dysregulation of Notch and UPR pathways. Interestingly, loss of Pcbp1 in cardiomyocytes disrupts alternative splicing of many important genes including Aars2, a gene associated with congenital mitochondrial cardiomyopathy. Pcbp1 deficiency resulted in creation of an Aars2 exon16-skipping variant, leading to its premature termination. eCLIP-seq showed that Pcbp1 primarily binds to CU-rich motifs at 3’UTR, distal intron and CDS regions of targets, and it interacts with regions of Aars2 transcript near exon 16. Using CRISPR/Cas9 technology, we knocked in loxP sites flanking the exon 16 of Aars2 (Aars2-Flox), and cross the floxed mice with cTNT-Cre mice to generate cardiac-specific exon16 deletion mutant of Aars2 (Aars2-cKO cTNT ). Intriguingly, abnormality in Aars2-cKO cTNT embryonic heart phenocopy aspects of ventricular non-compaction and malformation observed in Pcbp1-cKO cTNT heart. Accordingly, the transcriptome from hearts of Pcbp1-cKO cTNT and Aars2-cKO cTNT display high concordance and similarity and share strikingly common dysregulated pathways. Conclusions: We discover a novel function of Pcbp1 in heart development by regulating Notch and UPR pathways. Additionally, Pcbp1 is indispensable for Aars2 gene splicing, whose deficiency is associated with congenital cardiomyopathy. Our findings suggest modulating Pcbp1 in developing hearts may offer a novel therapeutic intervention for congenital heart failure.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
ZC3H4-a novel Cys-Cys-Cys-His-type zinc finger protein-is essential for early embryogenesis in mice†

Jianmin Su,Xiaosu Miao,Danielle Archambault,Jesse Mager,Wei Cui

DOI: https://doi.org/10.1093/biolre/ioaa215

2021-02-11

Abstract:Zinc finger domains of the Cys-Cys-Cys-His (CCCH) class are evolutionarily conserved proteins that bind nucleic acids and are involved in various biological processes. Nearly 60 CCCH-type zinc finger proteins have been identified in humans and mice, most have not been functionally characterized. Here, we provide the first in vivo functional characterization of ZC3H4-a novel CCCH-type zinc finger protein. Our results show that although Zc3h4 mutant embryos exhibit normal morphology at E3.5 blastocyst stage, they cannot be recovered at E7.5 early post-gastrulation stage, suggesting implantation failure. Outgrowth assays reveal that mutant blastocysts either fail to hatch from the zona pellucida, or can hatch but do not form a typical inner cell mass colony, the source of embryonic stem cells (ESCs). Although there is no change in levels of reactive oxygen species, Zc3h4 mutants display severe DNA breaks and reduced cell proliferation. Analysis of lineage specification reveals that both epiblast and primitive endoderm lineages are compromised with severe reductions in cell number and/or specification in the mutant blastocysts. In summary, these findings demonstrate the essential role of ZC3H4 during early mammalian embryogenesis.
Kctd10 Regulates Heart Morphogenesis by Repressing the Transcriptional Activity of Tbx5a in Zebrafish

Xiangjun Tong,Yao Zu,Zengpeng Li,Wenyuan Li,Lingxiao Ying,Jing Yang,Xin Wang,Shuonan He,Da Liu,Zuoyan Zhu,Jianming Chen,Shuo Lin,Bo Zhang

DOI: https://doi.org/10.1038/ncomms4153

IF: 16.6

2014-01-01

Nature Communications

Abstract:The T-box transcription factor Tbx5 (Tbx5a in zebrafish) plays a crucial role in the formation of cardiac chambers in a dose-dependent manner. Its deregulation leads to congenital heart disease. However, little is known regarding its regulation. Here we isolate a zebrafish mutant with heart malformations, called 34c. The affected gene is identified as kctd10, a member of the potassium channel tetramerization domain (KCTD)-containing family. In the mutant, the expressions of the atrioventricular canal marker genes, such as tbx2b, hyaluronan synthase 2 (has2), notch1b and bmp4, are changed. The knockdown of tbx5 rescues the ectopic expression of has2, and knockdown of either tbx5a or has2 alleviates the heart defects. We show that Kctd10 directly binds to Tbx5 to repress its transcriptional activity. Our results reveal a new essential factor for cardiac development and suggest that KCTD10 could be considered as a new causative gene of congenital heart disease.
Cyclin‐dependent kinase 13 is indispensable for normal mouse heart development

Qazi Waheed‐Ullah,Anna Wilsdon,Aseel Abbad,Sophie Rochette,Frances Bu'Lock,Asma Ali Saed,Marc‐Phillip Hitz,J. David Brook,Siobhan Loughna

DOI: https://doi.org/10.1111/joa.14175

2024-11-26

Journal of Anatomy

Abstract:Congenital heart disease (CHD) is the most common defect in live births. The role of cyclin‐dependent kinase (CDK13) in cardiogenesis and CHD was studied using a transgenic mouse model (Cdk13tm1b) carrying deletion of exons 3 and 4, causing loss of function. High‐resolution episcopic microscopy (HREM) allows detailed morphological analysis to be performed. A range of CHDs were found in the embryonic day E15.5 mouse heart, in both Cdk13tm1b heterozygotes and homozygotes. Ao, aorta; IVS; interventricular septum; LA, left atrium; LV, left ventricle; PT, pulmonary trunk; RA, right atrium; RV, right ventricle. Congenital heart disease (CHD) has an incidence of approximately 1%. Over the last decade, sequencing studies including large cohorts of individuals with CHD have begun to unravel the genetic mechanisms underpinning CHD. This includes the identification of variants in cyclin‐dependent kinase 13 (CDK13), in individuals with syndromic CHD. CDK13 encodes a serine/threonine protein kinase. The cyclin partner of CDK13 is cyclin K; this complex is thought to be important in transcription and RNA processing. Pathogenic variants in CDK13 cause CDK13‐related disorder in humans, characterised by intellectual disability and developmental delay, recognisable facial features, feeding difficulties and structural brain defects, with 35% of individuals having CHD. To obtain a greater understanding for the role that this essential protein kinase plays in embryonic heart development, we have analysed a presumed loss of function Cdk13 transgenic mouse model (Cdk13tm1b). The homozygous mutants were embryonically lethal in most cases by E15.5. X‐gal staining showed Cdk13 expression localised to developing facial regions, heart and surrounding areas at E10.5, whereas at E12.5, it was more widely present. In the E15.5 heart, staining was seen throughout. RT‐qPCR showed significant reduction in Cdk13 transcript expression in homozygous compared with WT and heterozygous hearts at E10.5 and E12.5. Detailed morphological 3D analysis of embryonic and postnatal hearts was performed using high‐resolution episcopic microscopy, which affords a more detailed analysis of structures such as cardiac valve leaflets and endocardial cushions, compared with more traditional histological techniques. We show that both the homozygous and heterozygous Cdk13tm1b mutants exhibit a range of CHD, including ventricular septal defects, bicuspid aortic valve, double outlet right ventricle and atrioventricular septal defects. 100% (n = 4) of homozygous hearts displayed CHD. Differential expression was seen in Cdk13tm1b homozygous mutants for two genes known to be necessary for normal heart development. The types of defects, and the presence of CHD in heterozygous mice (17.02%, n = 8/47), are consistent with the CDK13‐related disorder phenotype in humans. This study provides important insights into the effects of reduced function of CDK13 in the mouse heart and contributes to our understanding of the mechanism behind this disorder as a cause of CHD.

anatomy & morphology

Analysis of minicircle classes in Leishmania (Viannia) species.

Role of the CASZ1 transcription factor in tissue development and disease

CASZ1 Loss-of-function Mutation Associated with Congenital Heart Disease.

CASZ1 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

Critical Role of Znhit1 for Postnatal Heart Function and Vacuolar Cardiomyopathy

Loss of GLTSCR1 Causes Congenital Heart Defects by Regulating NPPA Transcription

Essential Role of MESP1-RING1A Complex in Cardiac Differentiation

Loss of Sec-1 Family Domain-Containing 1 (scfd1) Causes Severe Cardiac Defects and Endoplasmic Reticulum Stress in Zebrafish

The Axenfeld-Rieger Syndrome Gene FOXC1 Contributes to Left-Right Patterning

The Axenfeld–Rieger Syndrome Gene FOXC1 Contributes to Left–Right Patterning

Functional screening of congenital heart disease risk loci identifies 5 genes essential for heart development in zebrafish

Endothelial Loss of ETS1 Impairs Coronary Vascular Development and Leads to Ventricular Non-Compaction

Overexpression of Jazf1 induces cardiac malformation through the upregulation of pro-apoptotic genes in mice

SMC3 Contributes to Heart Development by Regulating Super-Enhancer Associated Genes.

Alteration in Connexin 43 Gap Junction Gene Dosage Impairs Conotruncal Heart Development

Chromatin Remodelling Complex Dosage Modulates Transcription Factor Function in Heart Development

Cardiotoxicity Related to Long‐Term Trastuzumab Therapy in Metastatic Breast Cancer: The Potential Role of Treatment Duration and Cardiac Risk Factors

Abstract P2059: Poly(rC)-binding Protein-1 (Pcbp1) Is Essential For Heart Development

ZC3H4-a novel Cys-Cys-Cys-His-type zinc finger protein-is essential for early embryogenesis in mice†

Kctd10 Regulates Heart Morphogenesis by Repressing the Transcriptional Activity of Tbx5a in Zebrafish

Cyclin‐dependent kinase 13 is indispensable for normal mouse heart development